RedHill Biopharma (2RH) Stock Forecast & Price Target
2RH Analyst Ratings
There are no analyst ratings in the last 3 months.
2RH Stock 12 Month Forecast
There are no analyst price targets in the last 3 months.
Detailed List of Analyst Forecasts
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | TipRanks - PerPlexity | EUR 0.33→EUR 0.38 | hold | -95.23%Downside | Upgraded | 11/03/26 | ||
| Google Drug Manufacturers - Specialty and Generic | TipRanks - Google | EUR 0.33→EUR 0.37 | sell | -95.36%Downside | Reiterated | 11/03/26 | ||
| Anthropic Drug Manufacturers - Specialty and Generic | TipRanks - Anthropic | EUR 0.33→EUR 0.38 | hold | -95.29%Downside | Upgraded | 11/03/26 | ||
| OpenAI - Gpt-5.6Sol | TipRanks - OpenAI | EUR 0.33→EUR 0.38 | hold | -95.29%Downside | Reiterated | 11/03/26 | ||
| DeepSeek - V4Pro | TipRanks - DeepSeek | EUR 0.33→EUR 0.38 | sell | -95.31%Downside | Reiterated | 11/03/26 | ||
| xAI - Grok-4.3 | TipRanks - xAI | EUR 0.33→EUR 0.38 | sell | -95.31%Downside | Downgraded | 11/03/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| PerPlexity - SonarReasoningPro | 11/03/26 | EUR 0.33→EUR 0.38 | hold | -95.23%Downside | Upgraded | TipRanks - PerPlexity | ||
| Google Drug Manufacturers - Specialty and Generic | 11/03/26 | EUR 0.33→EUR 0.37 | sell | -95.36%Downside | Reiterated | TipRanks - Google | ||
| Anthropic Drug Manufacturers - Specialty and Generic | 11/03/26 | EUR 0.33→EUR 0.38 | hold | -95.29%Downside | Upgraded | TipRanks - Anthropic | ||
| OpenAI - Gpt-5.6Sol | 11/03/26 | EUR 0.33→EUR 0.38 | hold | -95.29%Downside | Reiterated | TipRanks - OpenAI | ||
| DeepSeek - V4Pro | 11/03/26 | EUR 0.33→EUR 0.38 | sell | -95.31%Downside | Reiterated | TipRanks - DeepSeek | ||
| xAI - Grok-4.3 | 11/03/26 | EUR 0.33→EUR 0.38 | sell | -95.31%Downside | Downgraded | TipRanks - xAI |
Best Analysts Covering RedHill Biopharma
Copying DeepSeek Drug Manufacturers - Specialty and Generic's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +14.27% per trade.
Copying DeepSeek Drug Manufacturers - Specialty and Generic's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +14.27% per trade.
Copying DeepSeek Drug Manufacturers - Specialty and Generic's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +14.27% per trade.
2RH Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 0 | 0 | 0 | 0 | 0 |
In the current month, 2RH has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 2RH average Analyst price target in the past 3 months is ―.
2RH Financial Forecast
2RH Earnings Forecast
Next quarter’s earnings estimate for 2RH is -EUR 0.90 with a range of ― to ―. The previous quarter’s EPS was -EUR 0.90. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
2RH Sales Forecast
Next quarter’s sales forecast for 2RH is EUR 0 with a range of ― to ―. The previous quarter’s sales results were EUR 0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
